This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
- $100,000
Personalized-Phage plus Ertapenem and Advanced Kinetics / Synergy (P-PEAKS) a multicentre randomized control trial to eradicate Escherichia coli in recurrent female Urinary Tract Infections (UTIs).
CIHR · 2024 · Nominated PI
Personalized-Phage plus Ertapenem and Advanced Kinetics / Synergy (P-PEAKS) a multicentre randomized control trial to eradicate Escherichia coli in recurrent female Urinary Tract Infections (UTIs).
Principal investigators: German, Gregory J; Wijeysundera, Duminda N
Keywords: Antibiotic Resistance; Clinical Trail; Host Interactions; Personalized Medicine; Phage Therapy
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.